1-3 of 3
Nathan D Mathewson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Selective Support of CAR-T Cell Therapies By Cis-Targeted IL-2 Enhances Anti-Tumor Activity and Obviates the Need for Lymphodepletion in Non-Human Primates

Sara Sleiman, Tyler Hansen, Nathan D Mathewson, Feng Shen, Miroslaw Kozlowski, Olga Shestova, Maksim Shestov, Danuta Jarocha, Vanessa Gonzalez, Joseph A. Fraietta, Hannah Thomas, Jack Swain, Raimon Duran-Struuck, Kelly D. Moynihan, Paul Bessette, Chris Kimberlin, Meghana Sukthankar, Terrence Park, Andy Yeung, Ivana Djuretic, Saar Gill
Journal: Blood
Blood (2024) 144 (Supplement 1): 499.
https://doi.org/10.1182/blood-2024-198249
Published: 2024
Journal Articles

Targeting of the CD161 inhibitory receptor enhances T-cell–mediated immunity against hematological malignancies

Francesca Alvarez Calderon, Byong H. Kang, Oleksandr Kyrysyuk, Shiwei Zheng, Hao Wang, Nathan D. Mathewson, Adrienne M. Luoma, Xiaohan Ning, Jason Pyrdol, Xuan Cao, Mario L. Suvà, Guo-Cheng Yuan, K. Dane Wittrup, Kai W. Wucherpfennig
Journal: Blood
Blood (2024) 143 (12): 1124–1138.
https://doi.org/10.1182/blood.2023022882
Published: 2024
Includes: Supplemental data
Journal Articles

Selective Support of CAR-T Cell Therapies By Cis-Targeted IL-2 or IL-21 Cytokines Results in Enhanced Anti-Tumor Activity

Sara Sleiman, Nathan D Mathewson, Feng Shen, Kelly Moynihan, Wei Chen, Paul Bessette, Chris Kimberlin, Danielle Pappas, Terrence Park, Andy Yeung, Ivana Djuretic, Saar Gill
Journal: Blood
Blood (2022) 140 (Supplement 1): 10259–10260.
https://doi.org/10.1182/blood-2022-168411
Published: 2022